Saturday, November 8, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Jacobs Solutions Stock: Soars on Earnings Beat and Raised Outlook

Robert Sasse by Robert Sasse
August 5, 2025
in Stocks
0
Jacobs Solutions Stock
0
SHARES
3
VIEWS
Share on FacebookShare on Twitter

Jacobs Solutions outperformed analyst expectations with a 25% year-over-year surge in adjusted earnings per share to $1.62, surpassing the $1.53 forecast. Despite a slight revenue miss ($3.03B vs. $3.07B projected), the company expanded margins significantly, with adjusted EBITDA rising 13% to $314 million. Shares jumped 4% pre-market to $141.09, buoyed by a record $22.7 billion backlog—a 14% annual increase—driven by demand in data centers, life sciences, and water management. A strategic partnership with NVIDIA to develop AI factory digital twins further bolstered investor confidence.

Aggressive Capital Returns and Upgraded Guidance

The engineering firm announced a $653 million stock buyback program and a 10% dividend hike, reflecting strong cash flow. Management raised its 2025 adjusted EPS forecast to $6.00–$6.10 and signaled above-trend revenue growth for 2026. Its consulting arm saw 15% revenue growth, supported by UK public sector projects. With net debt at the low end of its target range (1.0–1.5x), Jacobs maintains robust financial flexibility amid accelerating demand.

Ad

Jacobs Solutions Stock: Buy or Sell?! New Jacobs Solutions Analysis from November 8 delivers the answer:

The latest Jacobs Solutions figures speak for themselves: Urgent action needed for Jacobs Solutions investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 8.

Jacobs Solutions: Buy or sell? Read more here...

Tags: Jacobs Solutions
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Royal Gold Stock
Stocks

Royal Gold Shares Surge to Record High on Acquisition Momentum

September 29, 2025
Unitedhealth Stock
Stocks

UnitedHealth Shares Present Conflicting Outlook for Investors

September 29, 2025
ASML Stock
Stocks

ASML Forges Strategic AI Alliance to Bolster Semiconductor Dominance

September 29, 2025
Next Post
Semrush Holdings Stock

Semrush Holdings Stock: Plunges Amid Downgrades and Weak Outlook

BMW Stock

BMW Stock: Legal Battle Escalates Over Faulty Brakes

Marathon Petroleum Stock

Marathon Petroleum Stock: Strong Q2 Earnings Amid Market Skepticism

Recommended

Finance_Cash

Analyst Maintains Hold Rating on Sunstone Hotel Investors with Increased Price Target

2 years ago
BASF Stock

BASF Strengthens Portfolio with $1.15 Billion Brazilian Coatings Unit Sale

1 month ago
Central Garden & Pet Company Stock

Institutional Investors Seize Opportunity in Central Garden & Pet Stock

3 months ago

Analyst Reaffirms Bullish Sentiment on Gaming and Leisure Properties

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Leslie’s Stock Navigates Choppy Waters Amidst Glimmers of Hope

Beyond Meat Shares Swing Wildly Amid Financial Turmoil and Operational Updates

Tech Stocks Face Mounting Pressure as Key Support Level Tested

Harvard Bioscience Stock: A Contradiction of Weak Earnings and Financial Improvement

Is the AI Dream Fading for Broadcom Stock?

Lemonade Stock Surges on AI-Powered Earnings Beat

Trending

CorVel Stock
AI & Quantum Computing

CorVel’s AI Strategy Faces Market Valuation Test

by Felix Baarz
November 8, 2025
0

CorVel Corporation finds itself at a critical juncture as the healthcare services provider delivers impressive quarterly results...

Jasper Therapeutics Stock

Jasper Therapeutics Faces Legal Storm Amid Clinical Trial Setbacks

November 8, 2025
Aqua Metals Stock

Aqua Metals Stock: Deep-Sea Venture and Earnings Report Set Stage for Volatility

November 8, 2025
Leslies Inc Stock

Leslie’s Stock Navigates Choppy Waters Amidst Glimmers of Hope

November 8, 2025
Beyond Meat Stock

Beyond Meat Shares Swing Wildly Amid Financial Turmoil and Operational Updates

November 8, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • CorVel’s AI Strategy Faces Market Valuation Test
  • Jasper Therapeutics Faces Legal Storm Amid Clinical Trial Setbacks
  • Aqua Metals Stock: Deep-Sea Venture and Earnings Report Set Stage for Volatility

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com